AltraBio participe à cette initiative qui réunit 15 partenaires pour un budget global de plus de 2,6 millions d’euros
Le 15 mars 2023, France – Le projet, intitulé SIGNATURE (SInGle cells iN AuToimmUne inflammatoRy disEases), s’inscrit dans le cadre du programme d’actions Marie Skłodowska-Curie et de Horizon Europe, le programme cadre de l’Union européenne pour la recherche et l’innovation. Ce réseau international formera des étudiants doctorants entreprenants, innovants et résilients, capable de faire face aux défis actuels et futurs, et de transformer les connaissances et les idées en des produits et des services qui apporteront bénéfices sociaux et économiques.
SIGNATURE is led by the Fundación Pública Andaluza Progreso y Salud in Spain, and more specifically by the researchers Marta Alarcón-Riquelme and Concepción Marañón Lizana. AltraBio has been collaborating with the foundation for 5 years, including in the framework of other large-scale European projects for research on autoimmune diseases and the development of precision medicine. Thirteen other partners are part of the network, including the academic partners such as University of Western Brittany in France, the Flemish Institute of Biotechnology in the Netherlands, the German Rheumatism Research Centre in Germany and the University of Catania in Italy, among others. Biotechnological companies such as Atrys Health and Altrabio are also actively participating in the network. En savoir plus
